https://www.news-medical.net/news/20230321/Next-gen-Mpro-inhibitor-Promising-new-drug-candidate-against-Omicron-and-other-SARS-CoV-2-variants.aspx
A recent Nature Signal Transduction and Targeted Therapy journal study demonstrated the potential antiviral activity of a new Mpro inhibitor (SY110) against SARS-CoV-2 Omicron and its sublineages.
Create an account or login to join the discussion